We send the latest information from SMC Laboratories.
We are pleased to introduce the development of drugs for non-alcoholic steatohepatitis (NASH) focusing on the gut microbiome and overview of studies using our STAM™ mice. Currently, the development of treatment and prevention methods for various diseases targeting the gut microbiome is progressing around the world. The relationship between NASH and the gut microbiome,…
In recognition of July 28th being World Hepatitis Day, we here at SMC thought it might be a good idea to help everyone around the globe have a deeper understanding of hepatitis, so please read on if you would like to learn more. In 2010, the World Health Organization (WHO) designated July 28th as…
Today, we are excited to invite you to join our Webinar that will be taking place on July 20th (JST) from 9:30 AM. In this webinar, we will focus on preclinical study for chronic kidney disease (CKD). In particular, we will introduce how to evaluate renal injury based on pathological findings, which is one…
I am writing you today to share with you about our Webinar. We occasionally organize webinars focusing on NASH and IPF, which are our primary areas of interest. We have previously conducted webinars on various topics, and the recordings are available in our webinar archive. ▶ Webinar archive [ Link ] The topics…
Today we are excited to invite you to join our Online Linkedin Webinar that will be taking place on May 18th (JST) from 9:30 AM. In this webinar, we will introduce STAM™ mice and give a lecture on the NAFLD activity score scoring method recommended by the FDA as the primary endpoint of clinical…
Today, in celebration of World Kidney Day, we would like to share with you a little bit about the campaigns history, as well as what the purpose of it is. World Kidney Day aims to raise awareness of the important role that the kidney plays, as well as reduce kidney disease and other related health problems….
Today, we would like to introduce our bile duct ligation (BDL)-induced primary biliary cirrhosis disease model. This BDL model reproduces the pathological features of cholestatic liver disease, which leads to acute liver injury followed by liver inflammation and severe fibrosis. It is a great model for those looking to conduct in-vivo screening studies…
Today we are excited to invite you to join our Online Linkedin Webinar that will be taking place on February 16th (JST) from 10:30 AM. In this webinar series we have being looking at examples of both clinical NASH trials as well as non-clinical study designs. For the 4th installment in this series, we…
World Cancer Day was established on February 4th, 2000, at the World Summit Against Cancer for the New Millennium in Paris initiated by UICC (Union for International Cancer Control). It is a day where people all around the world come together and join in the fight against cancer by raising public awareness of the disease….
Today we are excited to invite you to join our Online Linkedin Webinar that will be taking place next week on January 19th (JST) from 10:30 AM. In this webinar series we have being looking at examples of both clinical NASH trials as well as non-clinical study designs. For the 3rd installment in this…
We wish you a Happy and Prosperous New Year! If you are currently planning to begin a project this year, we would love to support you in any way we can, including conducting one of our high quality pharmacology studies. Today, we would like to share with you a little bit about the…
Today's topic is Fibrosis. We would like to discuss with you the importance of therapeutic treatments that target fibrosis. Fibrosis is involved in many diseases, so even if fibrosis is not your direct target, please read on. Fibrosis can occur in many different organs. It is caused by a disruption in the wound healing…